Securities and Exchange Commission Receives Recent Filings from Indivior and Sonoma Pharmaceuticals
Quick Brief
Recent regulatory filings submitted to the Securities and Exchange Commission provide updates from two pharmaceutical companies. Indivior Pharmaceuticals filed a current report detailing regulation FD disclosures and other events, while Sonoma Pharmaceuticals submitted information regarding matters voted on by security holders.
What Happened?
Indivior Pharmaceuticals, Inc. and Sonoma Pharmaceuticals, Inc. both submitted Form 8-K filings to the Securities and Exchange Commission. Indivior's filing included Item 7.01 for Regulation FD Disclosure, Item 8.01 concerning other corporate events, and Item 9.01 for financial statements and exhibits. Sonoma Pharmaceuticals submitted a filing addressing the submission of matters to a vote of security holders under Item 5.07.
Why It Matters
Form 8-K filings provide timely updates to investors and the public regarding significant corporate events, regulatory compliance, and shareholder voting outcomes, maintaining transparency in the financial markets.
Key Facts
- Indivior Pharmaceuticals filed an 8-K report containing Regulation FD disclosures and other corporate events.
- Sonoma Pharmaceuticals submitted an 8-K report covering the submission of matters to a vote of security holders.
- Both submissions were recorded through the SEC EDGAR filing system in September 2026.
Compiled from 1 outlet
Related Stories
Securities and Exchange Commission Filings Report Multiple Corporate Updates
Recent regulatory filings submitted to the Securities and Exchange Commission detail corporate updates from two firms. Aquestive Therapeutics filed disclosures under Regulation FD alongside other operational events. Meanwhile, Alaunos Therapeutics reported amendments impacting security holder rights and corporate bylaws.
Federal Reserve Implements First Interest Rate Hike in Three Years Amid Political Friction
The US Federal Reserve has approved its first interest rate increase in three years in a unanimous decision. The move went ahead despite vocal opposition from President Donald Trump, who had advocated for a rate cut instead. Financial markets and analysts are assessing the potential impacts on loans, mortgages, and broader economic policies.
Bank of England Keeps Rates at 3.75% and Warns of Potential Hikes Over Middle East Conflict
The Bank of England has decided to leave interest rates steady at 3.75%. Alongside the hold, officials cautioned that ongoing conflict in the Middle East might push inflation higher and force future rate increases. The central bank additionally revealed an unexpected initiative to sell billions in government bonds back to the Treasury.
Evaluating 12 Years of Modinomics as the Indian Economy Evolves
As Prime Minister Narendra Modi marks 12 years in office, analysts are examining the economic framework known as Modinomics. Rather than a single textbook formula, the term encompasses a diverse set of policy choices, growth strategies, and welfare initiatives implemented over the period.